Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0GW8L
|
|||
| Drug Name |
Pyrrole derivative 2
|
|||
| Synonyms |
PMID26161824-Compound-5
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Patented | [1] | |
| Company |
SANOFI-AVENTIS BARTH, Francis CONGY, Christian DUCOUX, Jean-Philippe RINALDI-CARMONA, Murielle
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H30Cl2N2O4S
|
|||
| Canonical SMILES |
C1CN(CCC1(C2=CC=CC=C2)C(=O)N)C(=O)C3=CC(=C(S3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)OCCCO
|
|||
| InChI |
1S/C32H30Cl2N2O4S/c33-23-9-12-25(27(34)19-23)29-26(21-7-10-24(11-8-21)40-18-4-17-37)20-28(41-29)30(38)36-15-13-32(14-16-36,31(35)39)22-5-2-1-3-6-22/h1-3,5-12,19-20,37H,4,13-18H2,(H2,35,39)
|
|||
| InChIKey |
WHNYDESPWWLRBM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Antagonist | [1] |
| Target's Patent Info | Cannabinoid receptor 1 (CB1) | Target's Patent Info | [1] | |
| KEGG Pathway | Rap1 signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Retrograde endocannabinoid signaling | ||||
| Panther Pathway | Endogenous cannabinoid signaling | |||
| Pathway Interaction Database | N-cadherin signaling events | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| BDNF signaling pathway | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. Expert Opin Ther Pat. 2015 Oct;25(10):1093-116. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.